UBS AM
OLMA icon

UBS AM’s Olema Pharmaceuticals OLMA Stock Holding History

UBS AM’s Portfolio OLMA Stock Details OLMA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$615K Buy
49,136
+24,111
+96% +$323K ﹤0.01% 2490
2026
Q1 		$373K Buy
25,025
+24,613
+5,974% +$548K ﹤0.01% 2617
2025
Q4 		$10.3K Buy
+412
New +$7.33K ﹤0.01% 2851
2025
Q1 		– Sell
-93,979
Closed -$548K – 2685
2024
Q4 		$548K Buy
93,979
+18,005
+24% +$180K ﹤0.01% 2545
2024
Q3 		$907K Sell
75,974
-7,616
-9% -$97.4K ﹤0.01% 2445
2024
Q2 		$904K Buy
83,590
+54,800
+190% +$594K ﹤0.01% 2429
2024
Q1 		$326K Buy
28,790
+7,412
+35% +$95.6K ﹤0.01% 2386
2023
Q4 		$300K Buy
+21,378
New +$287K ﹤0.01% 2419

Other funds holding OLMA

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $5.34B AUM 380.18% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
BCLSI
Bain Capital Life Sciences Investors Boston, Massachusetts $1.68B AUM 126.09% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.91B AUM 304.52% 1-Year Est. Return
SL
Siren LLC Greenwich, Connecticut $4.94B AUM 244.43% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
LGM
Logos Global Management San Francisco, California $2.32B AUM 536.01% 1-Year Est. Return

UBS AM's OLMA Position: Q2 2026 in Review

UBS AM increased its Olema Pharmaceuticals (OLMA) stake by 96% in Q2 2026, buying an estimated $323K and bringing the position to 49,136 shares worth $615K. The position accounts for ﹤0.01% of the portfolio, ranked #2490.

UBS AM first reported a position in OLMA in Q4 2023 and has held it in 8 quarters since. The position peaked at $907K in Q3 2024. 183 funds tracked by Wall St. Rank hold OLMA as of Q2 2026.

  • UBS AM held 49,136 shares of Olema Pharmaceuticals worth $615K as of Q2 2026.
  • UBS AM bought 24,111 Olema Pharmaceuticals shares in Q2 2026, an estimated $323K.
  • Olema Pharmaceuticals made up ﹤0.01% of UBS AM's portfolio in Q2 2026, its #2490 holding.
  • UBS AM first reported a position in Olema Pharmaceuticals in Q4 2023 and has held it in 8 quarters since.
  • UBS AM's Olema Pharmaceuticals position peaked at $907K in Q3 2024.
  • 183 funds tracked by Wall St. Rank held Olema Pharmaceuticals as of Q2 2026.

Based on UBS AM's 13F filing for Q2 2026, filed 13 Aug 2026.